Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Spain

Spain Articles

Industry

BMI View: The dire debt situation faced by Spain's autonomous governments will force them to continue widening cost containment measures. This extends beyond price cuts on medicines... 2013-01-15


Industry

BMI View: The sharp drop in public pharmaceutical expenditure in Spain during the second half of 2012 warns of a continuing fall in spending on medicines in 2013. BMI notes that this... 2013-01-04


Industry

BMI View: The deterioration of the Spanish economy and the government's implementation of increasingly aggressive fiscal austerity policies that focus on cost containment in the healthcare... 2012-09-26


More ARTICLES

Industry

BMI Core View: Governments will increasingly impose price controls on pharmaceuticals. Drugmakers have generally charged what the market will bear in both developed and emerging markets.... 2012-08-03


Industry

BMI View: The cash infusion to pay Spanish public sector hospital debt to drugmakers will only provide companies with brief respite. It is vital that the government establishes a long-term... 2012-07-05


Industry

BMI View: While the recently announced healthcare cost-containment measures in Spain do not include price cuts on medicines, we believe measures such as increased co-payments on medicines... 2012-06-29


Industry

BMI View: The drug markets of the EU5 countries, Germany, the UK, France, Spain and Italy, will experience a decline over the 2011-2016 forecast period. Our bearish outlook takes into... 2012-06-11


Industry

BMI View: While the Spanish government has pledged to pay back drugmakers that are owed money by public hospitals, we believe the slow speed of discussions and the growing public debt... 2012-05-30

Western Europe InsightWestern Europe Channels Western Europe Countries